Nadal Publications List 2016

Transcription

LIST OF PUBLICATIONS
David Nadal, born 18.04.1954
July 29, 2016
Dissertation
Das Menkes-Syndrom: Literaturübersicht und Darstellung zwei eigener Fälle. Med. Diss., Zürich, 1985.
PUBLICATIONS
a) Original Papers
1.
Nadal D, Plüss H-J, Jörg W, Hitzig WH. Das Hypereosinophiliesyndrom bei akuter lymphatischer
Leukämie. Schweiz Med Wochenschr 1986;116:1151-1154.
2.
Nadal D, Boltshauser E. Transient paraparesis following bacterial meningitis. Helv paediat Acta
1987;42:55-57.
3.
Nadal D, Baerlocher K. Menkes disease: long-term treatment with copper and D-penicillamine. Eur J
Pediatr 1988;147:621-625.
4.
Nadal D, Gundelfinger R, Flueler U, Boltshauser E. Acrodermatitis chronica atrophicans. Arch Dis
Child 1988;63:72-74.
5.
Nadal D, Schwöbel M, von Graevenitz A. Corynebacterium group D and urolithiasis in a boy with
megacalycosis. Infection 1988;16:245-247.
6.
Jendis JB, Tomasik Z, Hunziker U, Nadal D, Seger R, Wetzel J-C, Kind Ch, Schüpbach J. Evaluation of
diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland. AIDS
1988;2:273-279.
7.
Bernasconi C, Nadal D, Wüst J, Lips U, Boltshauser E. Food-borne botulism: an uncommon disorder.
Helv paediat Acta 1988;43:515-519.
8.
Hunziker UA, Nadal D, Jendis JB, Tomasik Z, Wetzel JC, Schüpbach J, Seger R. Stable HIVencephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial
prophylaxis. Eur J Pediatr 1989;148:417-422.
9.
Nadal D, Hunziker UA, Bucher HU, Hitzig WH, Duc G. Infants born to mothers with antibodies against
Borrelia burgdorferi at delivery. Eur J Pediatr 1989;148:426-427.
10. Nadal D, Hunziker UA, Schüpbach J, Wetzel J-C, Tomasik Z, Jendis JB, Fanconi A, Seger RA.
Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection. Arch Dis Child
1989;64:662-669.
11. Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A. Tumor necrosis factor in infectious
meningitis. Arch Dis Child 1989;64:1274-1279.
12. Bucher HU, Nadal D, Mieth D. Listeriose beim Neugeborenen: Bessere Prognose dank Früherkennung.
Monatsschr Kinderheilkd 1989;137:321-325.
13. Nadal D, Taverna Ch, Hitzig WH. Immunoblot analysis of antibody binding to polypeptides of Borrelia
burgdorferi in children with different clinical manifestations of Lyme disease. Pediatr Res 1989;26:377382.
14. Nadal D, Wunderli W, Briner H, Hansen K. Prevalence of antibodies to Borrelia burgdorferi in forestry
workers and blood donors from the same region in Switzerland. Eur J Clin Microbiol Infect Dis
1989;8:992-995.
15. Nadal D, Hunziker UA, Bauersfeld U, Pfister H, Hitzig WH. Infection with Staphylococcus aureus
producing toxic shock syndrome (TSS) toxin-1 without TSS. Eur J Pediatr 1989;148:318-319.
page 1 of 26
July 29, 2016
16. Nadal D, Wunderli W, Meurmann O, Briner J, Hirsig J. Isolation of respiratory syncytial virus from liver
tissue and extrahepatic biliary atresia material. Scand J Infect Dis 1990;22:91-93.
17. Nadal D, Herrmann P, Baumann A, Fanconi A. Acute mastoiditis: clinical, microbiological, and
therapeutic aspects. Eur J Pediatr 1990;149:560-564.
18. Nadal D, Albini B, Chen C, Schläpfer E, Bernstein JM, Ogra PL. Distribution and engraftment patterns
of human tonsillar mononuclear cells in mice with severe combined immunodeficiency: Role of the
Epstein-Barr virus. Int Arch Allergy Appl Immunol 1991;95:341-351.
19. Nadal D, Albini B, Schläpfer E, Chen C, Brodsky L, Ogra PL. Tissue distribution of mucosal antibodyproducing cells specific for respiratory syncytial virus in scid mice engrafted with human tonsils. Clin
Exp Immunol 1991;85:358-364.
20. Yalman N, Brändle B, Greiner J, Rutishauser M, Mühlebach TL, Hunziker UA, Nadal D, Schüpbach J,
Seger RA. Depression of antigen-specific immune responses: an early feature preceding symptoms in
vertical HIV-infection. Immunology and Infectious Diseases 1991;1:275-280.
21. Nadal D, Albini B, Schläpfer E, Bernstein JM, Ogra PL. Role of Epstein-Barr virus and interleukin-6 in
the development of lymphomas of human origin in SCID mice engrafted with human tonsillar
mononuclear cells. J Gen Virol 1992;73:113-121.
22. Chen C, Nadal D, Cohen SA, Mookerjee B, Vladutiu A, Stinson MW, Ogra PL, Albini B. Direct
demonstration of engraftment of human peripheral blood leukocytes (hu-PBL) in SCID mice. Int Arch
Allergy Appl Immunol 1992;97:295-300.
23. Nadal D, Soh N, Schläpfer E, Bernstein JM, Ogra PL. Distribution characteristics of immunoglobulinsecreting cells in adenoids. Relationship to age and disease. Int J Pediatr Otolaryngol 1992;24:121130.
24. Soh N, Nadal D, Schläpfer E, Bernstein JM, Ogra PL. Immunologic response of adenoidal lymphocytes
to respiratory syncytial virus. Ann Otol Rhinol Laryngol 1992;101:848-853.
25. Nadal D, de Roche B, Buisson M, Seger RA. Oral hairy leukoplakia in vertically and horizontally
acquired HIV infection. Arch Dis Child 1992;67:1296-1297.
26. Nadal D, Caduff R, Kraft R, Salfinger M, Bodmer T, Kirschner P, Böttger EC, Schaad UB. Invasive
infection with Mycobacterium genavense in three children with the acquired immunodeficiency
syndrome. Eur J Clin Microbiol Infect Dis 1993;12:37-43.
27. Nadal D, Lauener RP, Braegger CP, Kaufhold A, Simma B, Lütticken R, Seger RA. T cell activation and
cytokine release in streptococcal toxic shock-like syndrome. J Pediatr 1993;122:727-729.
28. Nadal D, von Graevenitz A. Routine detection of inducible ß-lactamase in gram-negative bacilli by
means of disk susceptibility testing. J Microbiol Methods 1993;17:283-291.
29. Weber R, Sauer B, Lüthi R, Nadal D. Intestinal coinfection with Enterocytozoon bieneusi and
Cryptosporidium in a human immunodeficiency virus-infected child with chronic diarrhea. Clin Infect
Dis 1993;17:480-483.
30. Richard B, Nadal D, Meuli M, Braegger CP. Acute acalculous cholecystitis in infective endocarditis. J
Pediatr Gastroenterol Nutr 1993;17:215-216.
31. Frei K, Nadal D, Pfister H-W, Fontana A. Listeria meningitis: identification of a cerebrospinal fluid
inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 1993;178:1255-1261.
32. Knecht H, Bachman E, Brousset P, Sandvej K, Nadal D, Bachman F, Odermatt BF, Delsol G, Pallesen
G. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and
identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937-2942.
33. Waldvogel K, Regnery RL, Anderson BE, Caduff R, Caduff J, Nadal D. Disseminated cat-scratch
disease: detection of Rochalimaea henselae in affected tissue. Eur J Pediatr 1994;153:23-27.
page 2 of 26
July 29, 2016
34. Nadal D, Caduff R, Frey E, Hassam S, Zimmermann DR, Seigneurin J-M, Plüss H-J, Seger RA. NonHodgkin's lymphoma in four children infected with the human immunodeficiency virus: association with
Epstein-Barr virus and treatment. Cancer 1994;73:224-230.
35. Gruner E, Bernasconi E, Galeazzi RL, Buhl D, Heinzle R, Nadal D. Brucellosis: an occupational hazard
for medical laboratory personnel. Report of five cases. Infection 1994;22:33-36.
36. Glarner H, Meuli M, Hof E, Galatti V, Nadal D, Fisch U, Stauffer UG. Management of petrous bone
fractures in children: Analysis of 127 cases. J Trauma 1994;36:198-201.
37. Braegger CP, Nadal D. Clarithromycin and pseudomembranous enterocolitis. Lancet 1994;343:241242. [Letter]
38. Kluger G, Schöttler A, Waldvogel K, Nadal D, Hinrichs W, Wündisch GF, Laub MC. Tickborne
encephalitis despite specific immunoglobulin prophylaxis. Lancet 1995;346:1502. [Letter]
39. Jacquier P, Nadal D, Zuber P, Eckert J. Zur Lage der Infektion mit Toxoplasma gondii bei der
schweizerischen Bevölkerung: Beitrag einer seroepidemiologischen Studie aus dem Kanton Zürich.
Schweiz Med Wochenschr 1995;125 (Suppl.65):23S-28S.
40. Guzman J, Frei K, Nadal D. In vitro immunization: generation of neutralizing monoclonal antibodies to
human interleukin-10. J Immunol Meth 1995;179:265-268.
41. Braegger CP, Albisetti M, Nadal D. Extensive esophageal candidiasis in the absence of oral lesions in
pediatric AIDS. J Pediatr Gastroenterol Nutr 1995;21:104-106.
42. Berger Ch, Albisetti M, Fanconi S, Rudin Ch, Cheseaux JJ, Micallef J, Kind C, Nadal D. Pneumocystiscarinii-Pneumonie bei Säuglingen mit vertikaler HIV-Infektion in der Schweiz. Schweiz Med
Wochenschr 1995;125:1162-1167.
43. Lauener RP, Hüttner S, Buisson M, Hossle JP, Albisetti M, Seigneurin J-M, Seger RA, Nadal D. T-cell
death by apoptosis in vertically HIV-infected children coincides with expansion of CD8+/interleukin-2
receptor-/HLA-DR+ T cells: sign of a possible role for herpes viruses as cofactors? Blood
1995;86:1400-1407.
44. Nadal D, Zbinden R. Serology to Bartonella (Rochalimaea) henselae may replace traditional diagnostic
criteria for cat-scratch disease. Eur J Pediatr 1995;154:906-908.
45. Zbinden R, Höchli M, Nadal D. Intracellular location of Bartonella henselae cocultivated with Vero cells
and used for an indirect fluorescent-antibody test. Clin Diag Lab Immunol 1995;2:693-695.
46. Solèr RA, Migliorati C, van Waes H, Nadal D. Thalidomide treatment of mucosal ulcerations in HIV
infection. Arch Dis Child 1996;74:64-65.
47. Neuhaus TJ, Iselin H, Nadal D. Haemophilus influenzae: a cause of peritonitis in peritoneal dialysis.
Nephrol Dial Transplant 1996;11:199-200.
48. Berger Ch, Pfyffer GE, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with
clarithromycin plus rifabutin. J Pediatr 1996;128:383-386.
49. Berger Ch, Braegger CP, Albisetti M, Landau K, Nadal D. Cerebral tuberculosis presenting as complex
febrile convulsions. Neuropediatrics 1996;27:161-163.
50. Stricker T, Willi UV, Pfyffer GE, Nadal D. A school-girl with constipation. Lancet 1996;348:306.
51. Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick-borne encephalitis following
passive immunization. Eur J Pediatr 1996;155:775-779.
52. Solèr RA, Howard M, Brink NS, Gibb D, Tedder RS, Nadal D. Regression of AIDS-related Kaposi’s
sarcoma during therapy with thalidomide. Clin Infect Dis 1996;23:501-503.
page 3 of 26
July 29, 2016
53. Ruef C, Fanconi S, Nadal D. Sternal wound infection after heart operations in pediatric patients
associated with nasal carriage of Staphylococcus aureus. J Thorac Cardiovasc Surg 1996;112:681686.
54. Steinlin MI, Nadal D, Eich GF, Martin E, Boltshauser EJ. Late intrauterine cytomegalovirus infection:
Clinical and neuroimaging findings. Pediatr Neurol 1996;15:249-253.
55. Nadal D, Guzman J, Fröhlich S, Braun DG. Human immunoglobulin preparations suppress the
occurrence of Epstein-Barr virus-associated lymphoproliferation. Exp Hematol 1997;25:223-231.
56. Spanaus K-S, Nadal D, Pfister H-W, Seebach J, Widmer U, Frei K, Gloor S, Fontana A. C-X-C and C-C
chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic
activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol
1997;158:1956-1964.
57. Richner B, Laurent D, Sunnarat Y, Bee D, Nadal D. Spread of HIV-1 to children in Cambodia. Lancet
1997;349:1451-1452.
58. Stahel PF, Nadal D, Pfister H-W, Paradisis PM, Barnum SR. Complement C3 and factor B
cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 1997;349:1886-1887.
59. Albisetti M, Schaer G, Good M, Boltshauser E, Nadal D. Diagnostic value of cerebrospinal fluid
examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology
1997;49:817-824.
60. Zbinden R, Michael N, Sekulovski M. von Graevenitz A. Nadal D. Evaluation of commercial slides for
detection of immunoglobulin G against Bartonella henselae by indirect immunofluorescence. Eur J Clin
Microbiol Infect Dis 1997;16:648-652.
61. Lahrtz F, Piali L, Nadal D, Pfister H-W, Spanaus K-S, Baggiolini M, Fontana A. Chemotactic activity on
mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-
inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol 1997;27:2484-2489.
62. Berger C, McQuain, C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H. The 30-bp deletion variant of
Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J
Infect Dis 1997;176:1370-1373.
63. Kind C, Rudin C, Siegrist C-A, Wyler C-A, Biedermann K, Lauper U, Irion O, Schüpbach J, Nadal D,
and the Swiss Neonatal HIV-Study Group. Prevention of vertical HIV transmission: additive protective
effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998;12:205-210.
64. Stricker T, Fröhlich S, Nadal D. Osteomyelitis and septic arthritis due to Citrobacter freundii and
Haemophilus influenzae type b. J Paediatr Child Health 1998;34:90-91.
65. Zbinden R, Ströhle A, Nadal D. IgM to Bartonella henselae in cat-scratch disease and during acute
Epstein-Barr virus infection. Med Microbiol Immunol 1998;186:167-170.
66. Kolb SA, Lahrtz F, Paul R, Leppert D, Nadal D, Pfister H-W, Fontana A. Matrix metalloproteinases and
tissue inhibitor of mettalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in
cerebrospinal fluid. J Neuroimmunol 1998;84:143-150.
67. Stricker T, Steinlin M, Willi UV, Nadal D. Hypoglossal nerve palsy associated with deep cervical
lymphadenopathy. Neurology 1998;50:1926-1927.
68. Bossart W, Nadal D. Intrauterine rubella virus infection despite anticipated maternal immunity. Eur J
Clin Microbiol Infect Dis 1998;17:597-599.
69. Ozsahin H, von Planta M, Müller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin
M, Crompton NEA, Seger RA. Successful treatment of invasive aspergillosis in chronic granulomatous
disease by bone marrow transplantation, G-CSF mobilized granulocytes, and liposomal AmphothericinB. Blood 1998;92:2719-2724.
page 4 of 26
July 29, 2016
70. Nadal D, Steiner F, Cheseaux JJ, Rudin C, Paediatric AIDS Group of Switzerland. Ritonavir promotes
increased growth in HIV-infected children. AIDS 1998;12:2356-2357.
71. Schmitt B, Wohrab G, Steinlin M, Fanconi S, Nadal D, Boltshauser E. Treatment with the N-methyl-Daspartate receptor antagonist dextromethorphan in severe bacterial meningitis: preliminary results. Eur
J Pediatr 1998;157:863-865.
72. Fischer JE, Janousek M, Nadal D, Fanconi S. Diagnostic techniques for ventilator-associated
pneumonia. Lancet 1998;352:1066. [Letter]
73. Huisman TA, Wohlrab G, Nadal D, Boltshauser E, Martin E. Unusual presentations of neuroborreliosis
in childhood. J Comput Assist Tomogr 1999;23:39-42.
74. Berger C, Rothenberger S, Bachmann E, McQuain C, Nadal D, Knecht H. Sequence polymorphisms
between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and
malignant lymphoproliferations. Int J Cancer 1999;81:371-375.
75. Zingg W, Bossart W, Berli E, Nadal D. Detection and quantification of cell-free Epstein-Barr virus by
polymerase chain reaction and subsequent DNA enzyme immuno assay. J Virol Methods
1999;79:141-148.
76. Zbinden R, von Graevenitz A, Rossi J, Kümin E, Berger-Bächi B, Hächler H, Nadal D. False positive lactamase results with Staphylococcus lugdunensis in the Vitek AutoMicrobic System. Zentralbl
Bakteriol 1999;289:365-370.
77. Nadal D, Böni J, Kind C, Varnier OE, Steiner F, Tomasik Z, Schüpbach J. Prospective evaluation of
amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric
human immunodeficiency virus type 1 infection. J Infect Dis 1999;180:1089-95.
78. Albisetti M, Braegger CP, Stallmach T, Willi UV, Nadal D. Hepatic steatosis: A frequent non-specific
finding in HIV-infected children. Eur J Pediatr 1999;158:971-974.
79. Michel K, Albisetti M, Pfyffer GE, Nadal D. Sporadic tuberculous meningoencephalitis. Infection
1999;27:370-371.
80. Nadal D, Berger C, Aebi C, Kind C. Prophylaxis for respiratory syncytial virus bronchiolitis. Lancet
1999;354:1997. [Letter]
81. Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in
clinical samples by real-time PCR. J Micobiol Methods 2000;41:45-51.
82. Fischer JE, Brunner A, Janousek M, Nadal D, Blau N, Fanconi S. Diagnostic potential of neutrophil
elastase inhibitor complex in the routine care of critically ill newborn infants. Eur J Pediatr
2000;159:659-662.
83. Meuli M, Lips U, Nadal D. A toddler with burns, stomatitis, and skin graft loss. Burns 2000;26:625-627.
84. Nadal D, Steiner F, Cheseaux JJ, Wyler Lazarevitch CA, Aebi C, Kind C, Rudin C, Pediatric AIDS
Group of Switzerland. Long-term responses to treatment including ritonavir or nelfinavir in HIV-1infected children. Infection 2000;28:287-296.
85. Fischer JE, Ramser E, Altermatt S, Nadal D, Waldvogel K. Rationaler Einsatz von Antibiotika beim
kritisch kranken Kind. Schweiz Med Wochenschr 2000;130:1564-1571.
86. Schüpbach J, Tomasik Z, Nadal D, Ledergerber B, Flepp M, Opravil M, Böni J. Use of HIV-1 p24 as a
sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. J
Antimicrob Agents 2000;16:441-445.
87. Nadal D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, Altwegg M. Community-acquired pneumonia
in children due to Mycoplasma pneumoniae: Diagnostic performance of a seminested 16S rDNA-PCR.
Diagn Microbiol Infect Dis 2001;39:15-19.
page 5 of 26
July 29, 2016
88. Benador D, Neuhaus TJ, Papazyan J-P, Willi UV, Engel-Bicik I, Nadal D, Slosman D, Mermillod B,
Girardin E. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute
pyelonephritis: effect on renal scarring. Arch Dis Child 2001;84:241-246.
89. Huisman TAGM, Holzmann D, Nadal D. MRI of chronic recurrent parotitis in childhood. J Comput
Assist Tomogr 2001;25:269-273.
90. Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr Virus (EBV) DNA
levels in serum during EBV-associated disease. J Med Virol 2001;64:505-512.
91. Greiner O, Day P, Bosshard P, Imeri F, Altwegg M, Nadal D. Quantitative Detection of Streptococcus
pneumoniae in nasopharyngeal secretions by real-time PCR. J Clin Microbiol 2001;39:3129-3134.
92. Güngör T, Engel-Bicik I, Eich G, Willi UV, Nadal D, Hossle JP, Seger RA, Steinert HC. Diagnostic and
therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-Dglucose in children with chronic granulomatous disease. Arch Dis Child 2001;85:341-345.
93. Abels S, Nadal D, Stroehle A, Bossart W. Reliable detection of respiratory syncytial virus infection in
children for adequate hospital infection control management. J Clin Microbiol 2001;39:3135-3139.
94. Steiner F, Kind C, Aebi C, Wyler-Lazarevitch CA, Cheseaux JJ, Rudin C, Molinari L, Nadal D. Growth in
human immunodeficiency virus type 1-infected children treated with protease inhibitors. Eur J Pediatr
2001;160:611-616.
95. Holzmann D., Willi U., Nadal D. Allergic Rhinitis as a risk factor for orbital complication of acute
Rhinosinusitis in children. Am J Rhinology 2001;15:387-390.
96. Berger C, Altwegg M, Meyer A, Nadal D. Broad-range polymerase chain reaction for diagnosis of ratbite fever caused by Streptobacillus moniliformis. Pediatr Infect Dis J 2001;20:1181-1182
97. Fleisch F, Zimmermann-Baer U, Zbinden R, Bischoff G, Arlettaz R, Waldvogel K, Nadal D, Ruef C.
Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis
2002;34:767-773
98. Nadal D, Blasius M, Niggli FK, Meier G, Berger C. Epstein-Barr virus (EBV) DNA levels in palatine
tonsils and autologous serum from EBV carriers. J Med Virol 2002;67:54-58.
99. Cheseaux JJ, Jotterand V, Aebi C, Gnehm H, Kind C, Nadal D, Rudin C, Wyler Lazarevitch CA, Nicod
P, Mooser V. Hyperlipidemia in HIV-infected children treated with protease inhibitors: Relevance for
cardiovascular diseases. J Acquir Immune Defic Syndr 2002;30:288-293.
100. Fischer JE, Benn A, Harbarth S, Nadal D, Fanconi S. Diagnostic accuracy of G-CSF, IL-8, and IL-1ra in
critically ill children with suspected infection. Intensive Care Med 2002;28:1324-1331.
101. Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K, Weller S. An investigation of the
steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. J Infect Dis
2002;186 (Suppl 1):S123-30.
102. Fischer JE,, Steiner F, Zucol F, Berger C, Martignon L, Bossart W, Altwegg M, Nadal D. Use of simple
heuristics to target macrolide prescription in children with community-acquired pneumonia. Arch
Pediatr Adolesc Med 2002;156:1005-1008.
103. Greiner O, Berger C, Day PJR, Meier G, Tang CM, Nadal D. Rates of detection of Neisseria
meningitidis in tonsils differ in relation to local incidence of invasive disease. J Clin Microbiol
2002;40:3917-3921.
104. Holzmann D, Funke G, Linder T, Nadal D. Turicella otitidis and Corynebacterium auris do not cause
otitis media with effusion in children. Pediatr Infect Dis J 2002;21:1124-1126.
105. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist
F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, da Silva Duarte
AJ, Tuerlinckx D, Virelizier J-L, Fischer A, Enright A, Bernhöft J, Cleary AM, Vermylen C, Rodriguezpage 6 of 26
July 29, 2016
Gallego C, Davies G, Blütters-Sawatzki R, Siegrist C-A, Ehlayel MS, Novelli V, Haas WH, Levy J,
Freihorst J, Al-Hajjar S, Nadal D, de Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K,
Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova J-L. Low penetrance, broad resistance, and
favorable outcome of Interleukin 12 receptor 1 deficiency: Medical and immunological implications. J
Exp Med 2003;197:527-535.
106. Greiner O, Day PJR, Altwegg M, Nadal D. Quantitative detection of Moraxella catarrhalis in
nasopharyngeal secretions by real-time PCR. J Clin Microbiol 2003;41:1386-1390.
107. Bonanomi A, Dohm C, Rickenbach Z, Altwegg M, Fischer J, Gygi D, Nadal D. Monitoring intracellular
replication of Chlamydophila (Chlamydia) pneumoniae in cell cultures and comparing clinical samples
by real-time PCR. Diagn Microbiol Infect Dis 2003;46:39-47.
108. Corti N, Sennhauser FH, Stauffer UG, Nadal D: Fosfomycin for the initial treatment of acute
haematogenous osteomyelitis. Arch Dis Child 2003;88:512-516.
109. Pabst WL, Altwegg M, Kind C, Mirjanic S, Hardegger D, Nadal D. Prevalence of enteroaggregative
Escherichia coli among children with and without diarrhea in Switzerland. J Clin Microbiol
2003;41:2289-2293.
110. Bonanomi A, Kojic D, Giger B, Rickenbach Z, Jean-Richard-Dit-Bressel L, Berger C, Niggli F, Nadal D.
Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by
standardized and calibrated real-time PCR and novel data processing. J Immunol Methods
2003;283:27-43.
111. Fischer JE, Seifarth FG, Baenziger O, Fanconi S, Nadal D. Hindsight judgement on ambiguous
episodes of suspected infection in critically ill children: poor consensus amongst experts? Eur J Pediatr
2003;162:840-843.
112. Potocki M, Goette J, Szucs TD, Nadal D. Prospective survey of antibiotic utilization in pediatric
hospitalized patients to identify targets for improvement of prescription. Infection 2003;31:398-403.
113. Audigé A, Schlaepfer E, Bonanomi A, Joller H, Knuchel MC, Weber M, Nadal D, Speck RF. HIV-1 does
not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo. J
Immunol 2004;172:2687-2696.
114. Glaeser C, Grimm F, Mathis A, Weber R, Nadal D, Deplazes P. Detection and molecular
characterisation of Cryptosporidium spp. isolated from diarrheic children in Switzerland. Pediatr Infect
Dis J 2004;23(4):359-361.
115. Berger C, Kindli K, Niggli FK, Nadal D. Withholding initial vancomycin in febrile neutropenia despite
implanted catheters. Eur J Pediatr 2004;163:422-423.
116. Giger B, Bonanomi A,Odermatt B, Ladell K, Speck RF, Kojic D, Berger C, Niggli FK, Nadal D. Human
tonsillar tissue block cultures differ from autologous tonsillar cell suspension cultures in lymphocyte
subset activation and cytokine gene expression. J Immunol Methods 2004;289 (1-2):179-190.
117. Battegay M, Berger C, Rochlitz C, Hurwitz N, Hirsch HH, De Geyter C, Haque T, Nadal D. Epstein-Barr
virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic lymphoma. Antiviral Therapy 2004;9:453-459.
118. Marty A, Marty A, Greiner O, Day PJR, Gunziger S, Mühlemann K, Nadal D. Detection of Haemophilus
influenzae type b by Real-Time PCR. J Clin Microbiol 2004;42:3813-3815.
119. Olah E, Berger C, Boltshauser E., Nadal D. Cerebral actinomycosis before adolescence.
Neuropediatrics 2004;35:239-241.
120. Mühlemann K, Franzini C, Aebi C, Berger C, Nadal D, Stähelin J, Gnehm HP, Posfay-Barbe K, Gervaix
A, Heininger U, Bonhoeffer J, Eich G, Kind C, Petignat C, Scalfaro P. Prevalence of nosocomial
infection in Swiss pediatric inpatients. Inf Control Hosp Epidemiol 2004;9:765-71.
page 7 of 26
July 29, 2016
121. Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-a-cath infections in children with cancer.
Eur J Cancer 2004;40:2452-2458.
122. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV
bronchiolitis. Arch Dis Child 2004;89:1155-1157.
123. Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of
sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory
prediction model: study protocol of a randomized controlled trial. Crit Care 2004;8:R443-R450.
124. Albisetti M, Lauener RP, Güngör T, Schär G, Niggli FK, Nadal D. Disseminated Fusarium oxysporum
infection in hemophagocytic lymphohistiocytosis. Infection 2004; 32(6):364-366.
125. Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB, Heininger U. Prospective
surveillance of hospitalisations associated with varicella-zoster virus infections in children and
adolescents. Eur J Pediatr 2005;164:366-370.
126. Gessler P, Pretre R, Bürki C, Rousson V, Frey B, Nadal D. Monocyte function-associated antigen
expression during and after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2005;130:54-60.
127. Huisman TAGM, Boltshauser E, Martin E, Nadal D. Diffusion tensor imaging in progressive multifocal
leukoencephalopathy: Early predictor for demyelination? Am J Neuroradiol 2005;26:2153-2156.
128. Brinkhof MWG, Böni J, Steiner F, Tomasik Z, Nadal D, Schüpbach J, the Swiss HIV Cohort Study
(SHCS), the Swiss HIV Mother + Child Cohort Study (MoCHiV). Evaluation of p24-based antiretroviral
treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between
consecutive visits. J Acquir Immune Defic Syndr 2006,41:557-562.
129. Bernasconi M, Berger C, Sigrist JA, Bonanomi A, Sobek J, Niggli FK, Nadal D. Quantitative profiling of
housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an
oligonucleotide microarray. Virology J 2006;3:43.
130. Schüpbach J, Tomasik Z, Knuchel M, Opravil M, Günthard HF, Nadal D, Böni J, the Swiss HIV Cohort
Study (SHCS), the Swiss HIV Mother + Child Cohort Study (MoCHiV). Optimized virus disruption
improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable
HIV-1 RNA under long-term HAART. J Med Virol 2006;78:1003-1010.
131. Zucol F, Ammann RA, Berger C, Aebi C, Altwegg M, Niggli FK, Nadal D. Real-time quantitative broadrange PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification.
J Clin Microbiol 2006;44:2750-2759.
132. Rao SP, Rechsteiner MP, Berger C, Sigrist JA, Nadal D*, Bernasconi M*. Zebularine reactivates
silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr
virus infection in Burkitt’s lymphoma Akata cells. Mol Cancer 2007;6:3.
*equal contribution
133. Knuchel MC, Jullu B, Sha C, Tomasik Z, Stoeckle MP, Speck RF, Nadal D, Mshinda H, Böni J, Tanner
M, Schüpbach J. Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J
Acquir Immune Defic Syndr 2007;44:247-253.
134. Ishii H, Ogino T, Berger C, Köchli-Schmitz N, Nagato T, Takahara M, Nadal D, Harabuchi Y. Clinical
usefulness of serum EBV DNA levels of BamHIW and LMP1 for nasal NK/T-cell lymphoma. J Med
Virol 2007;79:562-572.
135. Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D*, Bernasconi M*. Silencing of latent
membrane protein 2B (LMP2B) reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's
lymphoma Akata cells. J Gen Virol 2007;88:1454-1459.
*equal contribution
136. Ammann R, Zucol F, Aebi C, Niggli F, Kühne T, Nadal D. Real-time broad-range PCR versus blood
culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia. Support Care
Cancer 2007;15:637-641.
page 8 of 26
July 29, 2016
137. Berger C, Hug M, Gysin C, Molinari L, Frei M, Bossart W, Nadal D. Distribution patterns of β- and γHerpesviruses within Waldeyer's ring organs. J Med Virol, 2007;79:1147-1152.
138. Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli F, Speck R, Nadal D. Immune
activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol 2007;9:2055-2069.
139. Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D.
Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J
Virol 2008;82:1739-1747.
140. Dorner M, Zucol F, Berger C, Byland R, Melroe GT, Bernasconi M, Speck RF, Nadal D. Distinct ex vivo
susceptibility of B-cell subsets to Epstein-Barr virus infection according to differentiation status and
tissue origin. J Virol 2008;82:4400-4412.
141. Rudin C, Burri M, Shen Y, Rode R, Nadal D. Long-term safety and effectiveness of Ritonavir, Nelfinavir
and Lopinavir/Ritonavir in antiretroviral-experienced HIV-infected children. Pediatr Infect Dis J
2008;27:1-7.
142. De Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth
H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V,
Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L,
Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, Chapel H, Reid B,
Roifman C, Nadal D, Reichenbach J, Caragol I, Garty BZ, Dogu F, Camcioglu Y, Gülle S, Sanal O,
Fischer A, Abel L, Stockinger B, Picard C, Casanova JL. Mutations in STAT3 and IL12RB1 impair the
development of human IL-17-producing T cells. J Exp Med 2008;205:1543-1550.
143. Wiegering VA, Kellenberger CJ, Bodmer N, Bergstraesser E, Niggli F, Grotzer M, Nadal D, Bourquin JP. Conservative management of acute appendicitis in children with hematologic malignancies during
chemotherapy-induced neutropenia. J Pediatr Hematol Oncol 2008;30:464-467.
144. Neuhaus TJ, Berger C, Buechner K, Parvex P, Bischoff G, Goetschel P, Husarik D, Willi U, Molinari L,
Rudin C, Gervaix A, Hunziker U, Stocker S, Girardin E, Nadal D. Randomised trial of oral versus
sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr
2008;167:1037-1047.
145. Weber R, Berger C, Balmer C, Kretschmar O, Bauersfeld U, Pretre R, Nadal D*, Knirsch W*.
Interventions using foreign material to treat congenital heart disease in children increase the risk for
infective endocarditis. Pediatr Infect Dis J 2008;27:544-550.
*equal contribution
146. Bihl F, Berger C, Chisholm JV, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander
C, Mueller NJ, and the Swiss HIV Cohort Study. Cellular immune responses and disease control in
acute AIDS-associated Kaposi's sarcoma. AIDS 2009;23:1918-1922.
147. Dorner M, Brandt S, Tinguely M, Zucol F, Bourquin JP, Zauner L, Berger C, Bernasconi M, Speck RF,
Nadal D. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR
triggering enhances immunoglobulin production. Immunology 2009;128:573-579.
148. Myers C, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Siegrist CA, the Pediatric
Infectious Disease Group of Switzerland (PIGS), and the Swiss Mother & Child HIV Cohort Study
(MoCHIV). Determinants of vaccine immunity in the cohort of Human Immunodeficiency Virus-infected
children living in Switzerland. Pediatr Infect Dis J 2009;28:996-1001.
149. Gibb DM, Castro H, Compagnucci A, Klein N, Lallemant M, Lyall H, Nadal D, Ananworanich J, Babiker
A, Bunupuradah T, Darbyshire JH, De Rossi A, Gonzalez Tomé MI, Harper L, Kanjavanit S,
Marczynska M, Mofenson L, Monpoux F, Moye J, Muñoz-Fernández MA, Ngo-Giang-Huong N, Niehues
T, Saidi Y, Walker AS, Wintergerst U, Giaquinto C for PENTA. Response to planned treatment
interruptions in HIV infection varies across childhood. AIDS 2010;24:231-241.
150. Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E, Pandey P, Weber R,
Nadal D, Berger C, von Sonnenburg F, Keystone J, Leder K, for the GeoSentinel Surveillance Network
page 9 of 26
July 29, 2016
Clinical Infectious Diseases. Sex and gender differences in travel-associated disease. Clin Infect Dis
2010;50:826-832.
151. Rudin C, Wolbers M, Nadal D, Rickenbach M, Bucher HC; the Pediatric Infectious Disease Group of
Switzerland (PIGS) and the Swiss Mother and Child HIV Cohort Study (MoCHiV). Long-term safety and
effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. Arch Dis Child
2010;95:478-481.
152. Hofer U, Schlaepfer E, Baenziger S, Nischang M, Regenass S, Schwendener R, Kempf W, Nadal D,
Speck RF. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice.
PLoS Pathog 2010;6:1-10.
153. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C,
Tugizov S, Speck RF, Nadal D. β1 Integrin expression increases susceptibility of memory B-cells to
Epstein-Barr virus infection. J Virol 2010;84:6667-6677.
154. Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Beck
Popovic M, Ridolfi Lüthy A, Aebi C. Predicting adverse events in children with fever and chemotherapyinduced neutropenia: The prospective multicenter SPOG 2003 FN study. J Clin Oncol 2010;28:20082014.
155. Zauner L, Melroe GT, Sigrist JA, Rechsteiner MP, Dorner M, Arnold M, Berger C, Bernasconi M,
Schaefer BW, Speck RF, Nadal D. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV
BZLF1 transcription via histone modification. Oncogene 2010;29:4588-4598.
156. Hug M, Dorner M, Zucol Fröhlich F, Gysin C, Neuhaus D, Nadal D*, Berger C*. Pediatric Epstein-Barr
virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus.
J Infect Dis 2010;202:1192-1199.
*equal contribution
157. Audigé A, Taffé P, Rickenbach M, Battegay M, Vernazza P, Nadal D, Speck RF and the Swiss HIV
Cohort Study (SHCS). Low postseroconversion CD4 count and rapid decrease of CD4 density identify
HIV+ fast progressors. AIDS Res Hum Retroviruses 2010; 26:997-1005.
158. Audigé A, Schlaepfer E, von Wyl V, Miller RC, Vernazza P, Nadal D, Speck RF and the SHCS. B-cells
from HIV-infected patients with primary central nervous system lymphoma display an activated
phenotype and have blunted TNF-α response to TLR9 triggering. AIDS Res Hum Retroviruses
2010;26:1063-1074.
159. De Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S,
Jannière L, Rose Y, de Suremain M, Kong XF, Filipe-Santos O, Chapgier A, Picard C, Fischer A, Dogu
F, Ikinciogullari A, Tanir G, Al-Hajjar S, Al-Jumaah S, Frayha HH, AlSum Z, Al-Ajaji S, Alangari A, AlGhonaium A, Adimi P, Mansouri D, Ben-Mustapha I, Yancoski J, Garty BZ, Rodriguez-Gallego C,
Caragol I, Kutukculer N, Kumararatne DS, Patel S, Doffinger R, Exley A, Jeppsson O, Reichenbach J,
Nadal D, Boyko Y, Pietrucha B, Anderson S, Levin M, Schandené L, Schepers K, Efira A, Mascart F,
Matsuoka M, Sakai T, Siegrist CA, Frecerova K, Blüetters-Sawatzki R, Bernhöft J, Freihorst J,
Baumann U, Richter D, Haerynck F, De Baets F, Novelli V, Lammas D, Vermylen C, Tuerlinckx D,
Nieuwhof C, Pac M, Haas WH, Müller-Fleckenstein I, Fleckenstein B, Levy J, Raj R, Cohen AC, Lewis
DB, Holland SM, Yang KD, Wang X, Wang X, Jiang L, Yang X, Zhu C, Xie Y, Lee PP, Chan KW, Chen
TX, Castro G, Natera I, Codoceo A, King A, Bezrodnik L, Di Giovani D, Gaillard MI, de MoraesVasconcelos D, Grumach AS, da Silva Duarte AJ, Aldana R, Espinosa-Rosales FJ, Bejaoui M, Bousfiha
AA, Baghdadi JE, Ozbek N, Aksu G, Keser M, Somer A, Hatipoglu N, Aydogmus C, Asilsoy S,
Camcioglu Y, Gülle S, Ozgur TT, Ozen M, Oleastro M, Bernasconi A, Mamishi S, Parvaneh N,
Rosenzweig S, Barbouche R, Pedraza S, Lau YL, Ehlayel MS, Fieschi C, Abel L, Sanal O, Casanova
JL. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine
2010;89:381-402.
160. Santy K, Nan P, Chantana Y, Laurent D, Nadal D, Richner B. The diagnosis of brain tuberculoma by
1
H-magnetic resonance spectroscopy. Eur J Pediatr 2011;170:379-387.
page 10 of 26
July 29, 2016
161. Miller RC, Schlaepfer E, Baenziger S, Crameri R, Zeller S, Byland R, Audigé A, Nadal D, Speck RF.
HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J Immunol 2011;
41:1058-1069.
162. Agyeman P, Aebi C, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Beck Popovic
M, Leibundgut K, Bodmer N, Ammann RA. Predicting bacteremia in children with cancer and fever in
chemotherapy-induced neutropenia. Results of the prospective multicenter SPOG 2003 FN study.
Pediatr Infect Dis J;2011;30:e114-e119.
163. L'Huillier AG, Ferry T, Courvoisier DS, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Hirschel B,
Sottas C, Siegrist CA, Posfay-Barbe KM, the Pediatric Infectious Diseases Group of Switzerland
(PIGS), the Swiss HIV Cohort Study (SHCS) and the Swiss Mother & Child HIV Cohort Study
(MoCHiV). Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody
levels and avidity. HIV Med 2012;13:54-61.
164. Hunziker T, Berger C, Staubli G, Tschopp A, Weber R, Nadal D, Hatz C, Schlagenhauf P. Profile of
travel-associated illness in children, Zurich, Switzerland. J Travel Med 2012;19:158-162.
165. Lüthi F, Leibundgut K, Niggli FK, Nadal D, Aebi C, Bodmer N, Ammann RA. Serious medical
complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the
prospective multicenter SPOG 2003 FN study. Pediatr Blood Cancer 2012;59;90-95.
166. Noack J, Jordi M, Zauner L, Alessi D, Burch A, Tinguely M, Hersberger M, Bernasconi M*, Nadal D*.
TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9
polymorphism. Cell Death Dis 2012;3:e323.
*equal contribution
167. Santy K, Nan P, Chantana Y, Laurent D, Scheer I, Steinmann B, Nadal D, Richner B. Non-invasive
diagnosis of lung tuberculosis in children by single voxel 1H-magnetic resonance spectroscopy. Eur J
Pediatr 2012;171:1257-1263.
168. Crisinel PA, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kahlert C, Rudin C, Nadal D, Siegrist CA.
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected
children living in Switzerland. Clin Vaccine Immunol 2012;19:1751-1757.
169. Bansal V, Altermatt S, Nadal D, Berger C. Lack of benefit of preoperative antimicrobial prophylaxis in
children with acute appendicitis: a prospective cohort study. Infection 2012;40:635-641.
170. Bernasconi M, Ueda S, Krukowski P, Bornhauser BC, Ladell K, Dorner M, Sigrist JA, Campidelli C,
Aslandogmus R, Alessi D, Berger C, Pileri SA, Speck RF, Nadal D. Early gene expression changes by
Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for posttransplant lymphoproliferative diseases. Int J Cancer 2013;133:2341-2350.
171. Lünemann A, Vanoaica LD, Azzi T, Nadal D, Münz C. A distinct subpopulation of human NK cells
restricts B cell transformation by EBV. J. Immunol 2013;191:4989-4995.
172. Ueda S, Uchiyama S, Azzi T, Gysin C, Berger C, Bernasconi M, Harabuchi Y, Zinkernagel AS, Nadal D.
Oropharyngeal Group A Sreptococcal colonization disrupts latent Epstein-Barr virus infection. J Infect
Dis 2014;209:255-264.
173. Meyer Sauteur PM, Relly C, Hackenberg A, Stahr N, Berger C, Bloemberg GV, Jacobs E, Nadal D.
Mycoplasma pneumoniae intrathecal antibody responses in Bickerstaff brain stem encephalitis.
Neuropediatrics 2014;45:61-63.
174. Steppacher A, Scheer I, Relly C, Zacek B, Turk A, Altpeter E, Berger C, Nadal D. Unrecognized
pediatric adult-type tuberculosis puts school contacts at risk. Pediatr Infect Dis J 2014;33:325-328.
175. Selva L, Berger C, Garcia-Garcia JJ, de Paz H, Nadal D, Muñoz-Almagro C. Direct identification of
Streptococcus pneumoniae capsular types in pleural fluids by using multiplex PCR combined with
automated fluorescence-based capillary electrophoresis. J Clin Microbiol 2014;52:2736-2737.
page 11 of 26
July 29, 2016
176. Böttcher-Haberzeth S, Biedermann T, Klar AS, Pontiggia L, Rac J, Nadal D, Schiestl C, Reichmann E,
Meuli M. Tissue engineering of skin: human tonsil-derived mesenchymal cells can function as dermal
fibroblasts. Pediatr Surg Int 2014;30:213-222.
177. Haas F, Yamauchi K, Murat M, Bernasconi M, Yamanaka N, Speck RF, Nadal D. Activation of NF-kB
via endosomal toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation. J
Virol 2014;88:10002-10012.
178. Meyer Sauteur PM, Bleisch B, Voit A, Maurer FP, Relly C, Berger C, Nadal D, Bloemberg GV. Survey
of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in
Switzerland. Swiss Med Wkly 2014;144:w14041.
179. Azzi T, Lünemann A, Murer A, Ueda S, Béziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Münz C,
Chijioke O, Nadal D. Role for early-differentiated natural killer cells in infectious mononucleosis. Blood
2014;124:2533-2543.
180. Agyeman P, Kontny U, Nadal D, Leibundgut K, Niggli F, Simon A, Kronenberg A, Frei R, Escobar H,
Kühne T, Beck-Popovic M, Bodmer N, Ammann RA. A prospective multicenter study of
microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss
pediatric oncology group 2003 fever and neutropenia study. Pediatr Infect Dis J 2014;33:e219-e225.
181. Rac J, Haas F, Schumacher A, Middeldorp JM, Delecluse H-J, Speck RF, Bernasconi M, Nadal D.
Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.PLoS One 2015;10:e0123645.
182. Leuthard D, Berger C, Staubli G, Nadal D, Schmid S, Hamer D, Weber R, Schlagenhauf P.
Management of children with travel-related illness evaluated in a pediatric emergency room. Pediatr
Infect Dis J 2015;34:1279-1282.
183. Berger C, Bochud PY, Boggian K, Cusini A, Egli A, Garzoni C, Hirsch HH, Hoffmann M, Khanna N,
Manuel O, Meylan P, Nadal D, van Delden C, Weisser M, Mueller NJ. The swiss transplant cohort
study: lessons from the first 6 years. Curr Infect Dis Rep 2015;17:29:1-5.
184. Meyer Sauteur PM, Moeller A, Relly C, Berger C, Plecko B, Nadal D. Swiss national prospective
surveillance of paediatric Mycoplasma pneumoniae-associated encephalitis. Swiss Med Wkly
2016;146:w14222.
185. Kakalacheva K, Regenass S, Wiesmayr S, Azzi T, Berger C, Dale RC, Brilot F, Münz C, Rostasy K,
Nadal D, Lünemann JD. Infectious mononucleosis triggers generation of IgG auto-antibodies against
native myelin oligodendrocyte glycoprotein. Viruses 2016;8:51.
186. Judd A, Collins IJ, Lodi S, Olson A, Pantazis N, del Amo J, Duff C, Gennotte AF, Kristensen D,
Ledergerber B, Nadal D; Rojo Conejo P, Sabin C, Saidi Y, Salbøl Brandt R, Termote M, Thorne C,
Warszawski J, Gibb DM. Children and young people with perinatal HIV in Europe: epidemiological
situation in 2014 and implications for the future. Euro Surveill 2016;21(10):pii=30162.
b) Collaborative Studies
1.
Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ, and The International Registry of HIV-exposed
Twins. High risk of HIV-1 infection for first-born twins. Lancet 1991;338:1471-75.
2.
Kind C, Brändle B, Wyler CA, Calame A, Rudin C, Schaad UB, Schüpbach J, Senn HP, Perrin L, Matter
L, and the Swiss Neonatal HIV Study Group. Epidemiology of vertically transmitted HIV-1 infection in
Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992;151:442-448.
3.
Künzel M, Kind C und Pädiatrische AIDS-Gruppe Schweiz. Aufwachsen der Kinder HIV-positiver Mütter
in der Schweiz. Schweiz Med Wochenschr 1992;122:503-510.
4.
Schüpbach J, Tomasik Z, Jendis J, Böni J, Seger R, Kind C, and the Swiss Neonatal HIV Study Group.
IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. J AIDS 1994;7:421-427.
page 12 of 26
July 29, 2016
5.
Schüpbach J, Böni J, Tomasik Z, Jendis J, Seger R, Kind C, and the Swiss Neonatal HIV Study Group.
Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human
immunodeficiency virus type 1-infected infants. J Infect Dis 1994;170:318-24.
6.
Duliège A-M, Amos CI, Felton S, Biggar RJ, the International Registry of HIV-exposed Twins, and
Goedert JJ. Birth order, delivery route, and concordance in the transmission of human
immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995;126:625-632.
7.
Kind C, Paediatric AIDS Group of Switzerland. Mother-to-child transmission of human
immunodeficiency virus type 1: influence of parity and mode of delivery. Eur J Pediatr 1995;154:542545.
8.
Mühlemann K, Alexander ER, Pepe M, Weiss NS, Schopfer K, the Swiss Haemophilus Influenzae
Study Group. Invasive Haemophilus influenzae disease and epiglottitis among Swiss children from
1980 to 1993: Evidence for herd immunity among older age groups. Scand J Infect Dis 1996;28:265268.
9.
Schaad UB, Heynen G, the Swiss Tonsillopharyngitis Study Group. Evaluation ot the efficacy, safety
and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in
children: results of a multicenter, open comparative study. Pediatr Infect Dis J 1996;15:791-795.
10. Mühlemann K, Alexander ER, Weiss NS, Pepe M, Schopfer K, the Swiss Haemophilus Influenzae
Study Group. Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of
age in the vaccine era, Switzerland 1991-1993. Int J of Epidemiology 1996;25:1280-1285.
11. Paediatric European Network for Treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell count in
untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998;12:F1-F8.
12. Paediatric European Network for Treatment of AIDS (PENTA). A randomized double-blind trial of the
addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase
inhibitor therapy in HIV-infected children: the PENTA-4 trial. AIDS 1998;12:F151-F160.
13. Lorenzi P, Masserey Spicher V, Laubereau B, Hirschel B, Kind C, Rudin C, Irion O, Kaiser L, the Swiss
HIV Cohort Study, The Swiss Collaborative HIV and Pregnancy Study, the Swiss Neonatal HIV Study.
Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998;12:F241-F247.
14. Venetz I, Schopfer K, Mühlemann K, Swiss Pneumococcal Study Group. Paediatric, invasive
pneumococcal disease in Switzerland, 1985-1994. Int J Epidemiology 1998;27:1101-1104.
15. Thorne C, Newell M-L, Peckham CS, the European Collaborative Study on children born to HIVinfected mothers. Clinical and psychosocial service needs of children and families affected by human
immunodeficiency virus in Europe. E J Publ Health 1999;9:8-14.
16. The International Perinatal HIV Group, the Swiss Neonatal HIV Study. The mode of delivery and the
risk of vertical transmission of human immunodeficiency virus Type 1. N Engl J Med 1999;340:977987.
17. Kern WV, Cometta A, de Bock R, Langenaeken J, Paesmans M, Gaya H for the International
Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of
Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with
granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999;341:312-318.
18. Paediatric European Network for Treatment of AIDS (PENTA). Parents’ attitudes to their HIV-infected
children being enrolled into a placebo-controlled trial: the PENTA 1 trial. HIV Medicine 1999;1:25-31.
19. Wüst J, Frei R, the Swiss Cefepime Study group. Multicenter study of the in vitro activity of cefepime in
comparison with five other broad-spectrum antibiotics against clinical isolates of Gram-positive and
Gram-negative bacteria from hospitalized patients in Switzerland. Clin Microbiol Infect 1999;5:262269.
page 13 of 26
July 29, 2016
20. Thorne C, Newell M-L, Peckham CS, the European Collaborative Study on children born to HIVinfected mothers. Disclosure of diagnosis and planning for the future in HIV-affected families in Europe.
Child Care Health Dev 2000;26:29-40.
21. Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Woerner I, Babiker A, Paediatric European Network
for Treatment of AIDS (PENTA). Immune repopulation after HAART in previously untreated HIV-1infected children. Lancet 2000;355:1331-1332.
22. Sharland M, Gibb D, Giaquinto C, Paediatric European Network for Treatment of AIDS (PENTA).
Current evidence for the use of paediatric antiretroviral therapy – a PENTA analysis. Eur J Pediatr
2000;159:649-656.
23. Thorne C, Rudin C, Newell M-L, Kind C, Hug I, Gray L, Peckham CS, the European Collaborative Study
and the Swiss Mother + Child HIV Cohort Study. Combination antiretroviral therapy and duration of
pregnancy. AIDS 2000;14:2913-2920.
24. Paediatric European Network for Treatment of AIDS (PENTA). Five year follow up of vertically HIV
infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine:
the PENTA 1 trial. Arch Dis Child 2001;84:230-236.
25. The International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of
HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 2001;15:357-368.
26. Paediatric European Network for Treatment of AIDS (PENTA). Comparison of dual nucleosideanalogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who
have not previously been treated: the PENTA 5 randomised trial. Lancet 2002;359:733-740.
27. De Rossi A, Walker AS, Klein N, De Forni D, King D, Gibb DM, Paediatric European Network for
Treatment of AIDS (PENTA). Increased Thymic Output after Initiation of Antiretroviral Therapy in
Human Immunodeficiency Virus Type 1-Infected Children in the Paediatric European Network for
Treatment of AIDS (PENTA) 5 Trial. J Infect Dis 2002;186:312-320.
28. Pillay D, Walker AS, Gibb DM, de Rossi A, Kaye S, Ait-Khaled M, Muñoz-Fernandez M, Babiker A,
Paediatric European Network for Treatment of AIDS (PENTA). Impact of Human Immunodeficiency
Virus Type 1 Subtypes on Virologic Response and Emergence of Drug Resistance among Children in
the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J Infect Dis 2002;186:617625.
29. Marzolini C, Rudin C, Decosterd LA, Telenti A, Schreyer A, Biollaz J, Buclin T, Swiss Mother + Child
HIV Cohort Study. Transplacental passage of protease inhibitors at delivery. AIDS 2002;16:889-893.
30. Litalien C, Faye A, Compagnucci A, Giaquinto C, Harper L, Gibb DM, Jacqz-Aigrain E, Paediatric
European Network for Treatment of AIDS. Pharmacokinetics of nelfinavir and its active metabolite,
hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Pediatr Infect Dis J 2003;22:48-55.
31. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG,
Pittet D and the Fungal Infection Network of Switzerland (FUNGINOS). Epidemiology of Candidemia in
Swiss Tertiary Care Hospitals: Secular Trends, 1991-2000. Clin Infect Dis 2004;38:311-320.
32. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia
in HIV-infected children in Europe. AIDS 2004;18:1443-1451.
33. Scherer A, Frater J, Oxenius A, Agudelo J, Price DA., Günthard HF, Barnardo M, Perrin L, Hirschel B,
Phillips RE, McLean AR, The Swiss HIV Cohort Study. Quantifiable cytotoxic T lymphocyte responses
and HLA-related risk of progression to AIDS. PNAS 2004;101/33:12266-12270.
34. HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for
disease progression in untreated HIV-1-infected children. AIDS 2006;20:1289-1294.
35. Lapaire O, Irion O, Koch-Holch A, Holzgreve W, Rudin C, Hoesli I, the Swiss Mother and Child HIV
Cohort Study. Increased peri- and post-elective cesarean section morbidity in women infected with
page 14 of 26
July 29, 2016
human immunodeficiency virus-1: a case-controlled multicenter study. Arch Gynecol Obstet
2006;274:165-169.
36. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer
H, the Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive
treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis
2007;44:94-102
37. Cressey TR, Green H, Khoo S, Treluyer JM, Compagnucci A, Saidi Y, Lallemant M, Gibb DM and
Burger DM for the Paediatric European Network for Treatment of AIDS. Plasma Drug Concentrations
and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase
Inhibitors in HIV Type 1-Infected Children. Clin Infect Dis 2008;46:1601-1608
38. Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, Furrer H, van Cutsem G, Ledergerber B, Boulle A,
the Swiss HIV Cohort Study, the International Epidemiologic Databases to Evaluate AIDS in Southern
Africa. Public-health and individual approaches to antiretroviral therapy: township South Africa and
Switzerland compared. PLoS Med 2008;5:e148.
39. Brossard P, Boulvain M, Coll O, Barlow P, Aebi-Popp K, Bischof P, Martinez de Tejada B, the Swiss
HIV Cohort Study, the Swiss Mother and Child HIV Cohort Study. Is screening for fetal anomalies
reliable in HIV-infected pregnant women? A multicenter study. AIDS 2008;22:2013-2017.
40. Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B,
Martinez de Tejada B, the Swiss HIV Cohort Study, the Swiss Mother and Child HIV Cohort Study.
Antiretroviral treatment during pregnancy. AIDS 2008;22:2323-2330.
41. Jacqz-Aigrain E, Harrison L, Zhao W, Compagnucci A, Castro (née Green) H, Farrelly L, Saidi Y,
Hamadache D, Welch S, Wintergerst U, Forcat S, Hadjou G, Firtion G, Snowden W, Giaquinto C, Gibb
DM, Burger D for the Paediatric European Network for Treatment of AIDS. Pharmacokinetic study of
once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36
months. Antivir Ther 2010;15:297-305.
c) Reviews
1.
Lüdin CE, Nadal D, Gnehm HpE. Lyme-Krankheit (Erythema-migrans-Krankheit). Ther Umsch
1986;43:537-539.
2.
Baerlocher K, Nadal D. Das Menkes-Syndrom. Ergeb Inn Med Kinderhkd 1988;57:79-144.
3.
Hirsig J, Schwöbel M, Nadal D. Bedeutung pathophysiologischer Grundlagen der intestinalen Sekretion
für Diagnose und Therapie des Ileus. Z Kinderchir 1988;43:319-321.
4.
Nadal D, Ogra PL. Development of local immunity: role in mechanisms of protection against or
pathogenesis of respiratory syncytial viral infections. Lung 1990;168:S379-S387.
5.
Herrmann P, Nadal D, Baumann A, Fanconi A. Akute Mastoiditis: Erfahrungen an 73 Kindern. In:
Aktuelle Probleme der Otorhinolaryngologie. ORL 13. Hrsg. B Kellerhals, U Fisch, J Mann, D de
Montmollin, J-P de Reynier. Hans Huber, Bern, 1990, pp 32-38.
6.
Frei K, Nadal D, Fontana A. Intracerebral synthesis of tumor necrosis factor- and interleukin-6 in
infectious meningitis. Ann NY Acad Sci 1990;594:326-335.
7.
Bernasconi E, Nadal D, Vogt M. Verdacht auf Lyme-Borreliose: wie abklären, wen behandeln? Ther
Umsch 1992;49:257-262.
8.
Nadal D, Ogra PL. The middle ear: an immunoreactive organ. In: Immunobiology in Otology, Rhinology
and Laryngology. Proceedings of the Third International Academic Conference on
Immunobiology in Otology, Rhinology and Laryngology, Coronado, CA, USA, November 8-10,
1990. Eds. B.F. McCabe, J.E. Veldman and G. Mogi. Kugler Publications, Amsterdam/New York 1992,
pp 123-128.
page 15 of 26
9.
July 29, 2016
Nadal D, Ogra PL. Vaccination approaches for infections of the respiratory tract. In: Lim DJ, Bluestone
CD, Klein JO, Nelson JD, Ogra PL (eds). Recent Advances in Otitis Media with Effusion.
Proceedings of the Fifth International Symposium. Toronto: BC Decker 1993, pp 222-229.
10. Bernstein JM, Nadal D, Faden HF. Longitudinal characteristics of isotypic specificity of serum
bactericidal antibody against nontypable Haemophilus influenzae (NTHI). In: Lim DJ, Bluestone CD,
Klein JO, Nelson JD, Ogra PL (eds). Recent Advances in Otitis Media with Effusion. Proceedings
of the Fifth International Symposium. Toronto: BC Decker 1993, pp 184-187.
11. Nadal D, Vogt M. Klinik und Therapie der Infektionen mit Herpes-simplex- und Varicella-zoster-Virus in
der Praxis. Ther Umsch 1994;51:538-544.
12. Vaudaux B, Rudin Ch, Kind C, Schaad UB, Gnehm H.E, Nadal D, Suter S, Calame A, Hohlfeld P.
Toxoplasmose congénitale: prise en charge pédiatrique. Schweiz Med Wochenschr 1995;125 (Suppl.
65):70S-81S.
13. Albini B, Nadal D, Chen C, Schlapfer E, Mookerjee BK, Stulnig T, Ogra PL, Wick G, Cohen SA.
Assessment of engraftment and function of human tonsillar and blood mononuclear cells in
immunodeficient mice. Adv Exp Med Biol 1995;371 A:85-89.
14. Zedler C, Zedler-Spéhler D, Nadal D, van Waes H. Mundschleimhaut-Veränderungen bei Kindern.
Schweiz Monatsschr Zahnmed 1996;106:15-24.
15. Nadal D. Epstein-Barr-Virus in Tumorzellen: Blinder Passagier oder Steuermann? Vierteljahrsschrift
Naturforsch Ges ZH 1996;141/2:45-52.
16. Exhenry C, Nadal D. Vertical human immunodeficiency virus-1 infection: involvement of the central
nervous system and treatment. Eur J Pediatr 1996;155:839-850.
17. Nadal D, Zbinden R. Erkrankungen durch Bartonellen. Internist 1996;37:890-894.
18. Linder T, Funke G, Schmid S, Nadal D. Die akute Otitis media und der Tubenmittelohrkatarrh: ein
Ueberblick über die Pathogenese und Empfehlungen zur Therapie. Schweiz Med Wochenschr
1996;126:2223-2233.
19. Albisetti M, Nadal D. L’importance de la sérologie pour le diagnostic de la maladie des griffes de chat et
des autres bartonelloses. Méd et Hyg 1997;55:311-313.
20. Nadal D. Bekanntes und Neues zur Epstein-Barr-Virus-Infektion. Ther Umsch 1998;55:52-56.
21. Nadal D. Bahnen Viren und Bakterien einander den Weg für Infektionen? Labor und Medizin
1998;25:244-247.
22. Nadal D. Lungenerkrankungen bei HIV-infizierten Kindern. Schweiz Med Wochenschr 1998;128:13751384.
23. Nadal D. HIV-Infektion beim Kind: Beginnt der Horizont sich klarer abzuzeichnen? Schweiz Med
Wochenschr 1999;129:30-33.
24. Nadal D, Weber R. Diagnose und Therapie der akuten Tonsillopharyngitis durch Gruppe A hämolysierende Streptokokken. Schweiz Ärzteztg 1999;80:599-601.
25. Schupbach J, Tomasik Z, Boni J, Nadal D, Flepp M, Ledergerber B, Opravil M, Cone R. Use of HIV-1
p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment
failure. The Fourth European Conference on Experimental AIDS Research 1999;157-162.
26. Aebi C, Nadal D, Kind C, Pfister R, Barazzone C, Hammer J. Konsensus Statement zur Prävention von
Respiratory Syncytial Virus (RSV)-Infektionen beim Neugeborenen und Säugling mit dem
humanisierten monoklonalen Antikörper Palivizumab (SynagisTM). Schweiz Ärzteztg 1999;80:29272930.
page 16 of 26
July 29, 2016
27. Nadal D. Impfungen. Ther Umsch 1999;56:698-707.
28. Nadal D. Fortschritte im Verständnis der Pathogenese und der Prävention von bakterieller Otitis media
und Meningitis. Schweiz Med Wochenschr 1999;129:2017-2020.
29. Nadal D. Is the in-vitro interferon- release assay an adequate replacement for the tuberculin skin test?
Clin Infect Dis 2002;34:1457-1459.
30. Aebi C, Barazzone C, Hammer J, Kind C, Nadal D, Pfister RE. Update zum Konsensus-Statement zur
Prävention von Respiratory Syncytial Virus (RSV)-Infektionen bei Säuglingen mit dem humanisierten
monoklonalen Antikörper Palivizumab (Synagis). Paediatrica 2002;13:58-62.
31. Aebi C, Barazzone C, Günthardt J, Hammer J, Kind C, Nadal D, Pfammatter JP, Pfister RE. Konsensus
Statement zur Prävention von Respiratory Syncytial Virus (RSV)-Infektionen mit dem humanisierten
monoklonalen Antikörper Palivizumab (Synagis®). Paediatrica 2004;15(6):12-16.
32. Aebi C, Barazzone C, Günthardt J, Hammer J, Kind C, Nadal D, Pfammatter JP, Pfister RE. Consensus
concernant la prévention des infections par le virus respiratoire syncitial (VRS) avec l’anticorps
humanisé monoclonal palivizumab (Synagis®). Paediatrica 2004;15(6):17-19.
33. Kahlert Ch, Nadal D. Akutes Fieber beim Kleinkind. Ther Umsch 2006;63:659-665.
34. Kempf W, Meylan P, Gerber S, Aebi C, Agosti R, Büchner S, Coradi B, Garweg J, Hirsch HH, Kind C,
Lauper U, Lautenschlager S, Reusser P, Ruef C, Wunderli W, Nadal D for the Swiss Herpes
Management Forum. Swiss recommendations for the management of varicella zoster virus infections.
Swiss Med Wkly 2007;137:239-251.
35. Kahlert C, Nadal D. Toxische Schocksyndrome. Infektionen mit Toxin bildenden Staphylokokken und
Streptokokken im Kindesalter. Pädiat Prax 2008;71:613-619.
36. Rechsteiner MP, Bernasconi M, Berger C, Nadal D. Role of latent membrane protein 2 isoforms in
Epstein-Barr virus latency. Trends Microbiol 2008;16:520-527.
37. Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr 2011;170:11111127.
38. Zauner L, Nadal D. Understanding TLR9 action in Epstein-Barr virus infection. Front Biosci
2012;17:1219-1231.
39. Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Oriol M,
Meylan P, Nadal D, Weisser M, Mueller NJ, Transplant Infectious Diseases Working Group, Swiss
Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases.
Curr Opin Organ Transplant 2012;17:581-585.
40. Liese J, Abele-Horn M, Beer M, Forster J Heininger U, Nadal D, Rose M, Scholz H. Diagnose und
Behandlung der Pneumonie im Kindesalter. Monatsschr Kinderheilkd 2013;161:703-712.
41. Chijioke O, Azzi T, Nadal D, Münz C. Innate immune responses against Epstein Barr virus infection. J
Leukoc Biol 2013;94:1185-1190.
42. Karrer U, Nadal D. Epstein-Barr-Virus und infektiöse Mononukleose. Schweiz Med Forum
2014;14:226-232.
43. Meyer Sauteur PM, Jacobs BC, Spuesens EBM, Jacobs E, Nadal D, Vink C, van Rossum AMC.
Antibody responses to Mycoplasma pneumoniae: Role in pathogenesis and diagnosis of encephalitis?
PLOS Pathogens 2014;10:e1003983.
44. Bansal Zweifel V, Berger C, Nadal D, Grawe C. HIV und Schwangerschaft. Ther Umsch 2014;71:498502.
45. Nadal D, Arlettaz R, Berger C. Die vertikale HIV-Infektion kann heute erfolgreich verhütet werden, bleibt
aber eine Herausforderung. Ther Umsch 2014;71:503-508.
page 17 of 26
July 29, 2016
46. Niehues T, Nadal D. HIV/AIDS bei Kindern. Pädiatrie up2date 2014;2:107-125.
47. Wenger P, Frey U, Nadal D. Research dedicated to children: SwissPedNet with its international links
overcomes key barriers to proper research in paediatrics. Swiss Med Wkly 2014;144:w14006.
48. Lünemann A, Rowe M, Nadal D. Innate immune recognition of EBV. Curr Top Microbiol Immunol
2015;391:265-287.
49. Meyer Sauteur PM, Unger WWJ, Nadal D, Berger C, Vink C, van Rossum AMC. Infection with and
carriage of Mycoplasma pneumoniae in children. Front Microbiol 2016;7:329.
d) Book Chapters
1.
Baerlocher K, Nadal D. Metabolische Parameter nach Gabe verschiedener Kohlenhydrate - Qualitative
und quantitative Aspekte. In: Bedeutung hochmolekularer Kohlenhydrate in der Säuglings- und
Kinderernährung (Eds. Baerlocher K, Wachtel U) Georg Thieme Verlag, Stuttgart New York, 1984, pp
46-75.
2.
Nadal D. Chlamydieninfektionen. In Immunologie und Infektionskrankheiten. Fortbildung in der
Kinderheilkunde (Eds. Olbing H und Palitzsch D). Hansisches Verlagskontor, Lübeck, 1987, pp 115123.
3.
Nadal D, Joller P, Hitzig WH. Durch Infektion mit human immunodeficiency virus (HIV) erworbene
Immunschwäche (AIDS) im Kindesalter. In: Bachmann K-D, et al. (Eds.) Pädiatrie in Praxis und Klinik
Georg Thieme 1989, pp 541-555.
4.
Fontana A, Frei K, Gallo P, Leist TP, Leppert D, Malipiero UV, Nadal D. Immunoregulation in the central
nervous system: detection of cytokines in cerebrospinal fluid. In Marrosu MG, Cianchetti C, Tavolato B
(Eds.): Trends in Neuroimmunology. Plenum Press, New York, 1990, pp 77-86.
5.
Nadal D, Schläpfer E, Ogra PL. Homing characteristics of mucosal lymphoid tissue and functional
aspects of cellular mucosal immunity to respiratory syncytial virus. In Tsuchiya M, Nagura H, Hibi T,
Moro I (Eds.): Frontiers of Mucosal Immunology. Elsevier, Amsterdam, 1991, pp 133-137.
6.
Frei K, Nadal D, Ralph P, Fontana A. Cytokines in inflammatory brain diseases. In Cellular and cytokine
networks in tissue immunity. Wiley-Liss, Chichester, 1991, pp 91-98.
7.
Nadal D, Ogra PL. Tonsils: the gatekeeper of mucosal immunity? In Advances in Oto-RhinoLaryngology, Vol. 47. Tonsils: An Update, Karger, Basel, 1992, pp 76-79.
8.
Nadal D. Skelettinfektionen. In Pädiatrische Infektiologie. Editor Schaad UB. Hans Marseille Verlag
GmbH München, 1993, pp 409-424.
9.
Nadal D, Braegger CP, Knoflach P, Albini, B. Malabsorption syndromes. In Mucosal Immunology: Part
II: Mucosal Diseases. Eds. Ogra PL, Mestecky J, Lamm M, Strober W, McGhee J, Bienenstock J.
Academic Press, New York, 1994, pp 457-491.
10. Bernstein JM, Yamanaka N, Nadal D. Immunobiology of the tonsils and adenoids. In Mucosal
Immunology: Part II: Mucosal Diseases. Eds. Ogra PL, Mestecky J, Lamm M, Strober W, McGhee J,
Bienenstock J. Academic Press, New York, 1994, pp 625-640.
11. Nadal D. Virusinduzierte Immundysfunktion (ausgenommen HIV). In Pädiatrische Allergologie und
Immunologie, 3. Auflage. Eds. Wahn U, Seger R, Wahn V, Holländer GA. Urban und Fischer Verlag,
München, 1999, pp 542-551 and 4th Edition 2005, pp 699-709.
12. Berger C, Nadal D. Bakteriologische Diagnostik In Pädiatrische Pneumologie. Eds. Rieger C, von der
Hardt H, Sennhauser FH, Wahn U, Zach M. Springer Verlag Berlin, 1999, pp 259-266 and 2nd Edition
2004, pp 240-247.
page 18 of 26
July 29, 2016
13. Ziegler S, Nadal D. Antibakterielle Therapie. In Pädiatrische Pneumologie. Eds. Rieger C, von der Hardt
H, Sennhauser FH, Wahn U, Zach M. Springer Verlag Berlin, 1999, pp 321-339 and 2nd Edition 2004,
pp 300-318.
14. Nadal D. Infekte der oberen Atemwege. In Pädiatrische Pneumologie. Eds. Rieger C, von der Hardt H,
Sennhauser FH, Wahn U, Zach M. Springer Verlag Berlin, 1999, pp 679-706 and 2nd Edition 2004,
pp 630-656.
15. Nadal D, Berger C. Bakterielle Infektionen. In Lehrbuch Pädiatrie. Eds. Speer CP, Gahr M. Springer
Verlag Heidelberg, 2000, pp 411-468, 2nd Edition 2004, pp 471-524, 3rd Edition 2009, pp 383-426, and
4th Edition 2013, pp 371-412.
16. Nadal D. Einsatz von Immunglobulinen bei anderen Infektionen. In Klinischer Einsatz von intravenösen
Immunglobulinen. Editor Wahn V. UNI-MED Verlag Bremen 2000, pp 51-54; 2nd Edition 2003, pp 63-66;
and 4th Edition 2007, pp. 68-74.
17. Nadal D. Sekundäre Immundefekte (ausgenommen HIV). In Pädiatrie Grundlagen und Praxis. Eds.
Lentze MJ, Schaub J, Schulte FJ, Spranger J. Springer Verlag Heidelberg, 2001, pp 566-568; 2nd
Edition 2003, pp 609-611; 3rd Edition 2007, pp 642-645; and Eds. Hoffmann, Lentze, Spranger, Zepp.
4th Edition 2014, pp 721-724.
18. Nadal D. Erhöhte Infektanfälligkeit. In Pädiatrie Grundlagen und Praxis. Eds. Lentze MJ, Schaub J,
Schulte FJ, Spranger J. Springer Verlag Heidelberg, 2001, pp 574; 2nd Edition 2003, pp 617-618;
3rd Edition 2007, pp 651-652; and Eds. Hoffmann, Lentze, Spranger, Zepp. 4th Edition 2014, pp 735737.
19. Nadal D. Bartonella henselae: Katzenkratzkrankheit. In Pädiatrie Grundlagen und Praxis. Eds. Lentze
MJ, Schaub J, Schulte FJ, Spranger J. Springer Verlag Heidelberg, 2001, pp 713-715; 2nd Edition 2003,
pp 770-771; 3rd Edition 2007, pp 800-801; and Eds. Hoffmann, Lentze, Spranger, Zepp. 4th Edition
2014, pp 893-895.
20. Nadal D. Rickettsiosen. In Pädiatrie Grundlagen und Praxis. Eds. Lentze MJ, Schaub J, Schulte FJ,
Spranger J. Springer Verlag Heidelberg, 2001, pp 716-717; 2nd Edition 2003, pp 772-774; 3rd Edition
2007, pp 802-804; and Eds. Hoffmann, Lentze, Spranger, Zepp. 4th Edition 2014, pp 896-897.
21. Nadal D. Virale hämorrhagische Fieber. In Pädiatrie Grundlagen und Praxis. Eds. Lentze MJ, Schaub J,
Schulte FJ, Spranger J. Springer Verlag Heidelberg, 2001, pp 742-746; 2nd Edition 2003, pp 799-804;
22. Nadal D, Schroten H, Schulte FJ. Bakterielle Infektionen des zentralen Nervensystems. In Pädiatrie
Grundlagen und Praxis. Eds. Lentze MJ, Schaub J, Schulte FJ, Spranger J. Springer Verlag
Heidelberg, 2001, pp 1354-1360; 2nd Edition 2003, pp 1430-1437; 3rd Edition 2007, pp 1487-1492; and
Eds. Hoffmann, Lentze, Spranger, Zepp. 4th Edition 2014, pp 1734-1740.
23. Nadal D, Kieslich M. Virusinfektionen und antikörpervermittelte Krankheiten des Gehirns und des
zentralen Nervensystems. In Pädiatrie Grundlagen und Praxis. Eds. Lentze MJ, Schaub J, Schulte FJ,
Spranger J. Springer Verlag Heidelberg, 2001, pp 1360-1366; 2nd Edition 2003, pp 1437-1442;
24. Nadal D, Berger C. Bakterielle Infektionen beim Kind. ComMed Verlagsagentur Basel, 2003, pp 1-168.
25. Weiss M, Handrick W, Borte M, Nadal D, Spencker F-B, Stojanov S. Fieber unklarer Genese. In
Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und
Jugendlichen, 4th Edition, Futuramed Verlag München 2003, pp 168-180; and 5th Edition, Thieme
Verlag, Stuttgart 2009, pp 130-135.
26. Heininger U, Abele-Horn M, Jacobs E, Nadal D. Mykoplasmen-Infektionen. In Deutsche Gesellschaft für
Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen, 4th Edition,
Futuramed Verlag, München 2003, pp 523-526; 5th Edition, Thieme Verlag Stuttgart 2009, pp 388-389;
page 19 of 26
July 29, 2016
and Eds. Berner R, Bialek R, Borte M, Forster J, Heininger U, Liese JG, Nadal D, Roos R, Scholz H.
6th Edition 2013, pp 410-412.
27. Nadal D, Schroten H. Nocardiosen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI)
Handbuch: Infektionen bei Kindern und Jugendlichen, 4th Edition, Futuramed Verlag, München 2003, pp
527-530; 5th Edition, Thieme Verlag Stuttgart, 2009, pp 390-392; and Eds. Berner R, Bialek R, Borte M,
Forster J, Heininger U, Liese JG, Nadal D, Roos R, Scholz H. 6th Edition 2013, pp 413-415.
28. Scholz H, Ahrens P, Belohradsky BH, Heininger U, Liese J, Luckhaupt H, Nadal D, Nicolai T, Riedel F,
Rieger C. Atemwegsinfektionen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI)
Handbuch: Infektionen bei Kindern und Jugendlichen, 4th Edition, Futuramed Verlag München, 2003, pp
751-781; and 5th Edition, Thieme Verlag Stuttgart, 2009, pp 570-591.
29. Nadal D, Greiner O, Berger C, Day PJR, Tang CM. Detection of Neisseria meningitidis in tonsils varies
in relation to the frequency of invasive disease. In: Current Topics on Tonsils and Mucosal Barriers of
Upper Airways. International Congress Series 1257. Eds. Yamanaka N, Kuki K, Tamura S, Hotomi M.
ElsevierAmsterdam, 2003, pp 133-140.
30. Nadal D. Pediatric infectious diseases –Quo vadis 2015? In Pediatric Infectious Diseases Revisited.
Eds. Schroten H, Wirth S. Birkhäuser Verlag Basel, 2007, pp 485-496.
31. Nadal D. Application of immunoglobulins in other infections. In Clinical use of immunoglobulins. Eds.
Wahn V, Orange J. UNI-MED Verlag Bremen, 2008, pp 72-78.
32. Nadal D, Dehio C, Kempf V. Kapitel Bartonellosen. In Deutsche Gesellschaft für Pädiatrische
Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen, 5th Edition, Thieme Verlag
Stuttgart, 2009, pp 162-164; and Eds. Berner R, Bialek R, Borte M, Forster J, Heininger U, Liese JG,
Nadal D, Roos R, Scholz H. 6th Edition 2013, pp 166-168.
33. Beetz R, Berner R, Kuwertz-Bröking E, Nadal D, Roos R, Rösch W, Wagenlehner F, Weber L. Kapitel
Harnwegsinfektionen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch:
Infektionen bei Kindern und Jugendlichen, 5th Edition, Thieme Verlag Stuttgart, 2009, pp 622-635; and
Eds. Berner R, Bialek R, Borte M, Forster J, Heininger U, Liese JG, Nadal D, Roos R, Scholz H.
6th Edition 2013, pp 688-700.
34. Barben J, Berger C, Bodmer T, Egger JM, Merlani G, Helbling P, Janssens JP, Nadal D, Nicod L, Turk
A, Vukmirovic B, Zellweger JP, Zimmerli S. Handbuch Tuberkulose. Lungenliga Schweiz, Bundesamt
für Gesundheit 2011; pp 1-88.
35. Niehues T, Borte M, Dueckers G, Nadal D, Schulze I. Kapitel Passive Immuntherapie und –prophylaxe.
In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und
Jugendlichen. Eds. Berner R, Bialek R, Borte M, Forster J, Heininger U, Liese JG, Nadal D, Roos R,
Scholz H. Thieme Verlag Stuttgart, 6th Edition 2013, pp 44-47.
36. Nadal D, Schuster V. Kapitel Virostatika. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI)
Handbuch: Infektionen bei Kindern und Jugendlichen. Eds. Berner R, Bialek R, Borte M, Forster J,
Heininger U, Liese JG, Nadal D, Roos R, Scholz H. Thieme Verlag Stuttgart, 6th Edition 2013, pp 109114.
37. Schuster V, Korn K, Nadal D, Wagner H-J. Kapitel Epstein-Barr-Virus-Infektionen. In Deutsche
Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen.
Thieme Verlag Stuttgart, 6th Edition 2013, pp 249-251.
38. Schuster V, Nadal D, Roos R, Sauerbrei A. Kapitel Herpes-simplex-Virus-Infektionen. In Deutsche
Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen.
Thieme Verlag Stuttgart, 6th Edition 2013, pp 308-313.
39. Schuster V, Nadal D. Kapitel Humanes-Herpesvirus-Typ-6- und -Typ-7- und Typ-8-Infektionen. In
page 20 of 26
July 29, 2016
40. Magdorf K, Bialek R, Detjen AK, Haas WH, Henneke P, Nadal D, Ritz N. Kapitel Tuberkulose und
nichttuberkulöse mykobakterielle Krankheiten. In Deutsche Gesellschaft für Pädiatrische Infektiologie
(DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Eds. Berner R, Bialek R, Borte M, Forster
J, Heininger U, Liese JG, Nadal D, Roos R, Scholz H. Thieme Verlag Stuttgart, 6th Edition 2013, pp
551-570.
41. Schuster V, Bührer C, Hamprecht K, Müller A, Nadal D. Kapitel Zytomegalovirusinfektionen. In
42. Liese JG, Abele-Horn M, Forster J, Heininger U, Nadal D, Rose MA, Scholz H. Kapitel Pneumonie. In
43. Ehl S, Liese JG, Nadal D. Kapitel Das infektanfällige Kind. In Deutsche Gesellschaft für Pädiatrische
Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Eds. Berner R, Bialek R,
Borte M, Forster J, Heininger U, Liese JG, Nadal D, Roos R, Scholz H. Thieme Verlag Stuttgart, 6th
Edition 2013, pp 701
e) Varia
1.
Nadal D. Antibiotika bei akuter Otitis media? Praxis 1997;85:1790.
2.
Nadal D. Behandlung der herpetischen Gingivostomatitis mit Aciclovir bei Kindern. Praxis
1997;86:1867.
3.
Nadal D. Schutzimpfungen. Schweiz Ärztezeitung 1998;79:163.
4.
Nadal D. Retroviren beim Kind. Unimagazin 1999;2:26-30.
5.
Nadal D. Herpes genitalis – die stille Geschlechtskrankheit. Das Neugeborene ist das schwächste Glied
in der Herpes-simplex-Virus-Infektionskette. Hospitalis 2000;70:125.
6.
Nadal D. Nützen Antibiotika Kleinkindern mit Otitis etwas? Infomed-Screen 2000;4:29-30.
7.
Nadal D. Neuer Meningokokkenimpfstoff. Infomed-Screen 2000;4:55.
8.
Nadal D, Berger C, Niggli F. Retroviren beim Kind. Medical Journal 2000;6:25-26.
9.
Nadal D. Virusinfektionen beim Menschen. GWA 2001;5:299-303.
10. Nadal D. Akute Sinusitis: keine Vorteile von Antibiotika. Infomed-Screen 2001;5:45.
11. Nadal D. Medicina basada en la evidencia en enfermedades infecciosas pediátricas: controversias.
MTA-Pediatria 2002;23:387-400.
12. Pabst WL, Nadal D, Altwegg M. Diarrheagenic potential of Escherichia coli in children in a developed
country. J Clin Microbiol 2003;41:5836-5837. [Letter]
13. Nadal D. Comment to: Ashcroft DM, Dimmock P, Garside R et al. Efficacy and tolerability of topical
pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised
controlled trials. BMJ 2005;330:516-24 in Infomed-Screen 2005;9(5/6):34.
14. Nadal D. Kinderimpfungen: Akzeptanz. Prävention & Gesundheitsförderung im Kanton Zürich
2006;19:6.
page 21 of 26
July 29, 2016
15. Nadal D. Antibiotika bei Meningokokken-Verdacht? Infomed-Screen 2006;10:56.
MASTER THESES DIRECTED/SUBMITTED BY D. NADAL
1. Sascha Erbetta. Infektion von Tonsillenhistokulturen mit Epstein-Barr-Virus. Masterarbeit Institut für
Pharmazeutische Wissenschaften, ETH Zürich, 2004.
2. Jeannine Leuenberger. TLR9 expression during acute cellular EBV infection. Masterarbeit Institut für
3. Selina Elena Decurtins. Silencing of LMP2A gene with siRNA. Masterarbeit Institut für Pharmazeutische
Wissenschaften, ETH Zürich, 2004.
4. Ursina Cagienard. Die Aktivität von viralem LMP2A (im Verhältnis zum LMP2B) ist entscheidend für die
Aktivierung und Beendigung der Tumor fördernden latenten EBV Infektion. Masterarbeit Institut für
5. Christina Fehr. Nachweis von Epstein-Barr-Virus (EBV) Replikation mittels Southern blot und ELLISA.
Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2005.
6. Brigitte Kappeler. Erarbeitung eines funktionell steuerbaren RNAi-Systems gegen LMP2 des EpsteinBarr-Virus. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2005.
7. Matthias Weber. Wirkung von LMP2A und LMP2B auf die Aktivierung der lytischen EBV Infektion in der
BL Zelllinie Akata. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2006.
8. Martina Anna Arnold. Impact of MyD88 on the TLR9 signalling pathway in EBV-positive Burkitt's
lymphoma. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2008.
9. Rahel M. Eugster. LMP2B: effects on viral and cellular signalling in Epstein-Barr virus-transformed B
cells. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2008.
10. Andrea S. Stucki. Conditional activation of the immediate-early lytic genes BZLF1 and BRLF1 of the
oncogenic Epstein-Barr virus. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich,
2008.
11. Ursula Barbara Haussmann. Impact of innate immunity on murine -herpesvirus 68 infection and
persistence. Masterarbeit Medizinische Biologie, Universität Zürich, 2008.
12. Anne Marie Theisen. Regulation of Epstein-Barr virus entry into epithelial cells via telomerase and
heparin sulphate. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2009.
13. Natascha Andrea Wuillemin. The role of the EBV lytic promoter in the TLR9-mediated inhibition of lytic
infection. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2009.
14. Tamara Bösch. Real-time qPCR as a valid alternative to plaque assay for the detection and
quantification of MHV-68 levels in various sample types. Masterarbeit Institut für Pharmazeutische
15. Andrea Burch. Establishment of a hormone-inducible system fort he EBV lytic master transcription factor
Zta in Burkitt's lymphoma cell lines. Masterarbeit Institut für Pharmazeutische Wissenschaften, ETH
Zürich, 2011.
16. Anna Steppacher. Cavitary pulmonary tuberculosis in children hospitalised at the University Children's
Hospital of Zurich 1990-2011. Masterarbeit Medizinische Fakultät, Universität Zürich, 2012.
17. Monika Murat. Role of tlr9 in latent y-herpesvirus infections. Masterarbeit Institut für Pharmazeutische
page 22 of 26
July 29, 2016
18. Roberta Aslandogmus. DNA damage response after infection with the tumor-associated Epstein-Barr
virus. Masterarbeit Human Biology, Mathematisch Naturwissenschaftliche Fakultät, Universität Zürich,
2012.
19. Andrina Schumacher. Susceptibility of epithelial AGS cells to infection by cell-free Epstein-Barr virus
mimicking in vivo conditions and establishment of a primary epithelial cell model. Masterarbeit Institut für
20. Corinne Peng. Age-dependent innate immune response during Epstein-Barr virus infection. Masterarbeit
Institut für Pharmazeutische Wissenschaften, ETH Zürich, 2013.
21. Jeannine Marty. Investigation of the signaling pathway linking TLR9 triggering to suppression of EBV
lytic reactivation. Master Thesis in Molecular and Cellular Biology, University of Zurich, 2013.
22. Barbara Rita Bleisch. Optimierung der Indikationsstellung Mycoplasma pneumoniae – Polymerase Chain
Reaction Diagnostik bei Kindern mit Pneumonie. Masterarbeit Medizinische Fakultät, Universität Zürich,
2015.
23. Andrea Nadia Frei. Invasive enteritische Salmonelleninfektionen beim Kind. Masterarbeit der
Medizinischen Fakultät, Universität Zürich, 2015.
24. Linda Schadt. Phenotype and function of T helper cells in malignant interaction with B-acute lymphoblastic leukemia cells. Master Thesis Institute of Pharmaceutical Sciences, ETH Zürich, 2016.
25. Kathrin Selina Heuberger. Invasive Streptokokken A Infekte im Universitäts-Kinderspital Zürich zwischen
2000 und 2012. Masterarbeit der Medizinischen Fakultät, Universität Zürich, 2016.
MD or PhD THESES DIRECTED/SUBMITTED BY D. NADAL
1.
Agnes Baumann. Akute Mastoiditis im Kindesalter: Eine retrospektive Analyse an 73 Kindern. Med.
Diss., Zürich 1991.
2.
Alexander Spillmann. Ueber die Bedeutung von Makroskopie und Mikroskopie in der Schnellerfassung
von experimentellen Bakteriämien mittels des BCB-Systems "Roche". Med. Diss., Zürich 1991.
3.
Christian Johannes Taverna. Immunoblot-Untersuchungen bei Kindern mit unterschiedlichen klinischen
Manifestationen der Lyme-Borreliose. Med. Diss., Zürich 1991.
4.
Hans Rudolf Briner. Frühsommer-Meningo-Enzephalitis und Lyme-Borreliose bei Forstarbeitern aus
dem Kanton Solothurn: Eine epidemiologische Untersuchung. Med. Diss., Zürich 1992.
5.
Tatjana Marva Gass. Die tonsilla palatina: Ein Reservoir für das Epstein-Barr-Virus? Med. Diss., Zürich
1997.
6.
Manuel Martin Haschke. Die Rolle respiratorischer Viren bei der Ätiologie der Epiglottitis im Kindesalter.
Med. Diss., Zürich 1997.
7.
Lorenzo Lanzicher. Appendicitis perforata im Kindesalter: Trimethoprim-Sulfamethoxazol und
Ornidazol, sowie Bakteriologie und Resistenzverhalten. Med. Diss., Zürich 1999.
8.
Sibylle Ziegler. Prädiktive Aussagekraft der Mikroskopie von Trachealsekret intubierter Kinder bezüglich
bakterieller Affektion im unteren Respirationstrakt. Med. Diss., Zürich 1999.
9.
Daniel Hardegger. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR.
10. Martin Jürgen Blasius. Quantifizierung von Epstein-Barr-Virus in Tonsillen mittels der Real-Time
Polymeraseketten-Reaktion. Med. Diss., Zürich 2001.
page 23 of 26
July 29, 2016
11. Oliver Greiner. Quantitative Detection of Streptococcus pneumoniae in Nasopharyngeal Secretions by
Real-Time PCR. Med. Diss., Zürich 2002.
12. Natascia Corti. Antimicrobial Treatment of Acute Haematogenous Osteomyelitis in Children. A review of
114 cases. Med. Diss., Zürich 2002.
13. Christina Saner. Chemokines and matrix metalloproteinases in cerebrospinal fluid from children with
leukemia: relation with involvement of the central nervous system. Med. Diss., Zürich 2003.
14. Werner Lukas Pabst. Diarrheagenic potential of Escherichia coli in children in a developed country.
15. Mihael Potocki. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify
targets for improvement of prescription. Med. Diss., Zürich 2004.
16. Claudia Gläser. Detection and molecular characterization of Cryptosporidium spp. isolated from
diarrheic children in Switzerland. Med. Diss., Zürich 2004.
17. Walter Zingg. Impact of an outbreak of Norovirus infection on hospital resources. Med. Diss., Zürich
2004.
18. Laurent Antoine Duttweiler. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis.
19. Bettina Giger. Human tonsillar tissue block cultures differ from autologous tonsillar cell suspension
cultures in lymphocyte subset activation and cytokine gene expression. Med. Diss., Zürich 2005.
20. Adrian Philipp Marty. Detection of Haemophilus influenzae Type b by Real-Time PCR. Med. Diss.,
Zürich 2005.
21. Sara Andrea Klingenfuss. Cytokine measurements in tracheal aspirates of critically ill children with
suspected ventilator associated pneumonia. Med. Diss., Zürich 2007.
22. Sieta Padmaja Rao. Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not
induce switching from latent to lytic Epstein-Barr virus infection in Burkitt’s lymphoma Akata cells. Med.
23. Markus Rechsteiner. Function of latent membrane protein 2B in EBV-positive Burkitt's lymphoma.
Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2008.
24. Marcus Dorner. Impact of innate and adaptive immunity on Epstein-Barr virus infection and persistence.
25. Nadine Payer. Suggested markers for sepsis in critically ill pediatric patients: Accuracy of sCD14, GCSF, IL-6, and IL-8 for advanced diagnosis. Med. Diss., Zürich 2009.
26. Ludwig Zauner. Impact of Toll-like receptors on Epstein-Barr virus and Burkitt's lymphoma.
27. Nicole Alexandra Berger. FIP (Fungal Immunomodulatory Protein) of Flammulina velutipes. Med. Diss.,
Zürich 2010.
28. Simone Melanie Brandt-dit-Siméon. Plasma cell toll-like receptor (TLR) expression differs from that of B
cells, and plasma cell TLR triggering enhances immunoglobulin production. Med. Diss., Zürich 2010.
29. Marta Wehrmüller. TLR9 triggering-induced suppression of Epstein-Barr virus lytic reactivation in
Burkitt's lymphoma cells requires the full-length episome and is associated with histone modifications
on Zp promoter. Med. Diss., Zürich 2013.
30. Florian Haas. The impact of toll-like receptor signaling on murine herpesvirus 68 infection in vitro and in
vivo. Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2014.
page 24 of 26
July 29, 2016
31. Patricia Krukowski. α4 integrin enhances susceptibility of B cells to Epstein-Barr virus infection.
32. Jürgen Rac. Impact of telomerase activity and toll-like receptor 9 activation on Epstein-Barr virus
infection in epithelial cells. Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2014.
33. Tarik Azzi. Role of Natural Killer Cells in Epstein-Barr virus infection. MathematischNaturwissenschaftliche Fakultät Diss., Zürich 2014.
34. Anna Christina Lara Steppacher. Unrecognized pediatric adult-type tuberculosis puts school contacts at
risk. Med. Diss., Zürich 2015.
35. Csongor Péter Deák. Rationale Diagnostik häufiger Infektionen im Kindesalter – Ein Leitfaden für Ärzte
im Kinderspital Zürich. Med. Diss., Zürich 2015.
36. Duo Li. The role of SOCS in HIV-1 pathogenesis in vivo. Mathematisch-Naturwissenschaftliche Fakultät
PhD THESES COMMITTEE MEMBER
1.
Regina Miller. The role of SOCS in HIV infection. Mathematisch-Naturwissenschaftliche Fakultät Diss.,
Zürich 2009.
2.
Vanessa Jane Craig. Novel insights into the molecular pathogenesis of gastric MALT lymphoma.
3.
Giovanni Sais. Comprehensive characterization of BKV Large T antigen epitopes to promote the
expansion of effectors T lymphocytes across a wide range of HLA class I and II antigens in prostate
cancer patients. Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2011.
4.
Emilie Zürcher. Characterization of Epstein-Barr virus-encoded latent membrane protein 1.
Mathematisch-Naturwissenschaftliche Fakultät Diss., Lausanne 2012.
5.
Petra Schuberth. NY-ESO-1 re-directed effector memory and central memory T cells for the treatment
of multiple myeloma. Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2012.
6.
Walther Hänseler. Development of a silencing resistant myelospecific next generation gene therapy
vector for gene therapy of the p47phox-deficient form of chronic granulomatous disease. MathematischNaturwissenschaftliche Fakultät Diss., Zürich 2013.
7.
Nicolas Ponroy. Statins inhibit cytomegalovirus replication by interfering with the isoprenoid arm of the
mevalonate pathway. Mathematisch-Naturwissenschaftliche Fakultät Diss., Zürich 2014.
8.
Olga Antsiferova. Control of EBV by latent and lytic antigen-specific cytotoxic T cells. MathematischNaturwissenschaftliche Fakultät Diss., Zürich 2014.
9.
Paula Luciana Codo. GDF-15, microRNAs and the immunophenotype of glioblastoma. MathematischNaturwissenschaftliche Fakultät Diss., Zürich 2014.
10. Pascal Hänggi. Keep dementia in mind, but forget memory formation: Plasticity of the N-methyl-Daspartate receptor in erythroid cells and its potential for the treatment of sickle cell anemia. .
HABILITATION DIRECTED BY D. NADAL
1.
Dr. Christoph Berger. The latent membrane protein 1, a viral oncogene and receptor mimicry in EpsteinBarr virus-associated reactive and malignant lymphoproliferation. Habilitation Zürich, 2001.
page 25 of 26
2.
July 29, 2016
Dr. Michele Bernasconi. Targeted tumor therapies. Habilitation Zürich, 2015.
page 26 of 26

Nadal Publications List 2016

Transcription

Similar documents

Einfluss von hormonellen Kontrazeptiva auf das Größenwachstum

BIOMEDICAL SIDE EFFECTS OF DOPING Biomedical Side Effects

Federal Health Reporting

RSV